Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
June 13, 2022
The new name Hemolens Diagnostics fully reflects the direction in which our company is evolving, bringing together critical elements of technology.
Over the past 7 years, we have successfully implemented a number of strategic projects to create a unique technology for the non-invasive diagnosis of coronary heart disease, which will soon revolutionize the world of medicine and be available to Polish patients.
The first part of the name ‘Hemo’ comes from the word hemodynamics, which is a branch of medicine that deals with the dynamics of blood flow. Lens’, on the other hand, emphasizes the company’s focus on diagnostics based on computer-assisted fluid flow analysis, which we develop and deliver to patients in Poland and Europe.
Intended Use:
Cardiolens FFR-CT Pro is a coronary physiologic simulation software for the clinical quantitative and qualitative analysis of previously acquired Coronary Computed Tomography Angiography (CCTA) and optionally with Continuous Non-invasive Blood Pressure (CNBP) data for assessment of patients with suspected Chronic Coronary Syndromes (CCS). It provides hemodynamic diagnostic factor FFR-CT (Fractional Flow Reserve with Computed Tomography), a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images and optionally from CNBP measurement. The factor FFR-CT at the output of Cardiolens FFR-CT Pro device is intended to support the functional evaluation of coronary artery disease. The Cardiolens FFR-CT Pro outputs are provided to support qualified clinicians to aid in the evaluation and assessment of coronary arteries. The results of Cardiolens FFR-CT Pro are intended to be used by qualified clinicians in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgment.